Primary market momentum on Dalal Street is set to remain vibrant next week as agrochemicals and seeds major Crystal Crop Protection Limited prepares to launch its ₹456 crore (₹455.49 crore) Initial Public Offering (IPO) on Wednesday, November 18, 2026. Having fixed a price band of ₹259 to ₹272 per equity share (face value of ₹10 each), the mainboard public issue offers retail and institutional investors a fresh opportunity to participate in India’s expanding agricultural inputs sector. For investors tracking upcoming IPO listings across Mumbai, New Delhi-NCR, Ahmedabad, Bengaluru, Pune, and agricultural hubs across Uttar Pradesh including Lucknow and Kanpur, the three-day subscription window will remain open through Friday, November 20, 2026, ahead of proposed listings on both the BSE and NSE.

Key Dates, Lot Size, and Reservation Structure for Retail Investors

Before placing bids, prospective applicants should note the complete schedule and bidding rules finalized by the company in consultation with its merchant bankers. Bidding for anchor investors will take place a day ahead of the public launch on Tuesday, November 17, 2026, followed by public subscription from November 18 to November 20, 2026. According to the issue schedule, the basis of share allotment is tentatively slated for Monday, November 23, 2026, with refunds initiated and shares credited to demat accounts on Wednesday, November 25, 2026, ahead of market debut on Thursday, November 26, 2026.

For retail individual investors, the minimum application lot size has been fixed at 55 equity shares, with subsequent bids permitted in multiples of 55 shares. At the upper end of the price band at ₹272 per share, a single retail lot requires a minimum capital outlay of ₹14,960, while retail applicants can bid for up to 13 lots (715 shares), representing a maximum retail investment of ₹1,94,480. Under SEBI allocation norms, not more than 50 percent of the net issue is earmarked for Qualified Institutional Buyers (QIBs), at least 35 percent is reserved for Retail Individual Investors (RIIs), and not less than 15 percent is allocated to Non-Institutional Investors (NIIs). Eligible employees bidding under the employee reservation portion will also receive a discount of ₹25 per equity share.

Fresh Issue and Offer for Sale: How IPO Proceeds Will Be Utilized

Crystal Crop Protection’s public offering combines primary capital raising with a partial secondary stake sale. The ₹455.49 crore book-built issue comprises a fresh issue of 1.31 crore equity shares aggregating up to ₹354.77 crore (approximately ₹355 crore) and an Offer for Sale (OFS) of 37.03 lakh equity shares worth up to ₹100.71 crore (approximately ₹101 crore). In the OFS component, promoter Ankur Aggarwal is the sole selling shareholder, while existing institutional backers—including the International Finance Corporation (IFC) and IFC Emerging Asia Fund—opted to retain their holdings rather than divest shares in the public offer.

While proceeds from the OFS portion will accrue directly to the selling promoter, funds generated from the ₹355 crore fresh issue will flow into Crystal Crop Protection’s balance sheet to strengthen financial flexibility and fund expansion. Specifically, the company plans to deploy ₹247.94 crore toward the full or partial repayment and prepayment of its own existing borrowings, alongside investing ₹22.06 crore in its material subsidiary, Saffire Crop Science Private Limited (also referred to as Sapphire Crop Science), to pare down subsidiary debt obligations. The remaining net proceeds will be utilized to pursue inorganic growth through strategic acquisitions and corporate initiatives, as well as general corporate purposes.

Business Overview and Financial Track Record of Crystal Crop Protection

Incorporated in 1994, Crystal Crop Protection has evolved into a research-driven Indian agri-inputs enterprise operating across two core pillars: agrochemicals and seeds. Its comprehensive crop protection portfolio spans herbicides, fungicides, and insecticides marketed under more than 174 established brands in farmer-friendly pack sizes. Beyond conventional crop protection, the company manufactures natural and biological crop nutrition products—including biostimulants, bioprotectants, plant growth regulators, liquid fertilizers, and micronutrients—while its seeds division produces hybrid and open-pollinated seeds for cotton, cereals, oilseeds, fodder crops, vegetables, and flowers.

Supported by manufacturing facilities across Maharashtra, Gujarat, Haryana, and Jammu and Kashmir, Crystal Crop Protection distributes its products nationwide through a vast network of more than 13,000 independent distributors and 36 distribution centers spanning 23 states and four union territories, alongside international exports to markets such as Japan, the United States, Thailand, Bangladesh, and Nepal. Financially, the company has demonstrated steady top-line and bottom-line momentum: in FY26 (ended March 31, 2026), consolidated total income rose 16 percent year-on-year to ₹3,180.98 crore from ₹2,731.94 crore in FY25, while profit after tax (PAT) climbed 22 percent to ₹144.91 crore from ₹118.39 crore, with first-quarter FY27 profit reaching ₹135.78 crore on income of ₹1,209.21 crore.

Lead Managers, Registrar, and Key Factors for Investors to Weigh

To manage the public offering, Crystal Crop Protection has appointed DAM Capital Advisors Limited, IIFL Capital Services Limited, and Motilal Oswal Investment Advisors Limited as the Book Running Lead Managers (BRLMs), while MUFG Intime India Private Limited serves as the official registrar to the issue. At the upper price band of ₹272 per share, the company commands an estimated post-issue market capitalization of approximately ₹4,438 crore.

For retail investors evaluating whether to subscribe when bidding opens on November 18, market analysts emphasize weighing Crystal Crop Protection’s broad pan-India distribution reach, deleveraging benefits from debt repayment, and rising share of higher-margin branded formulations against inherent industry risks—such as monsoon variability, seasonal working-capital cycles, and raw material price fluctuations. Reviewing the Red Herring Prospectus (RHP) carefully and aligning bids with individual risk appetite remains essential before applying.